Immediate Impact
70 standout
Citing Papers
GLP-1-based therapies for diabetes, obesity and beyond
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
Works of Priya Manjoo being referenced
Management of type 2 diabetes, obesity, or nonalcoholic steatohepatitis with high‐dose GLP‐1 receptor agonists and GLP‐1 receptor‐based co‐agonists
2023
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Priya Manjoo | 110 | 55 | 51 | 12 | 211 | |
| Sharonjeet Kaur | 56 | 93 | 22 | 13 | 267 | |
| U. Gudat | 183 | 43 | 20 | 11 | 279 | |
| J A Thomson | 147 | 35 | 35 | 23 | 274 | |
| Elena A. Christofides | 182 | 40 | 30 | 10 | 260 | |
| Giuseppe Di Pasquale | 192 | 13 | 77 | 16 | 285 | |
| Hannah Mathew | 86 | 84 | 72 | 12 | 284 | |
| Fiona Ivison | 166 | 52 | 48 | 13 | 289 | |
| Giovanni Rossini | 119 | 59 | 48 | 10 | 293 | |
| Radomir Stevanovic | 103 | 37 | 26 | 8 | 270 | |
| Rok Herman | 101 | 57 | 25 | 17 | 293 |
All Works
Login with ORCID to disown or claim papers
Loading papers...